_id
6919e9c93c536f8df23182d5
Ticker
IMM.LSE
Name
ImmuPharma PLC
Exchange
LSE
Address
One Bartholomew Close, London, United Kingdom, EC1A 7BL
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.immupharma.co.uk
Description
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company's lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140, which is in Phase II clinical trial for the treatment of chronic inflammatory demyelinating polyneuropathy, a rare acquired autoimmune disorder of peripheral nerve; and P140 that covers other indications acute and chronic asthma, gout, irritable bowel disease, and periodontitis. Its pre-clinical products include BioAMB, a peptide-based drug of Amphotericin-B formulations for the treatment of serious and life-threatening fungal infections, such as aspergillosis; and BioCin, a vancomycin based treatment for anti-infection. It has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of 1P40 platform; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.
Last Close
60000
Volume
493490
Current Price
7.2
Change
1.6666666666666607
Last Updated
2025-12-30T11:05:51.054Z
Image
https://logo.clearbit.com/www.immupharma.co.uk
Ipo Date
-
Market Cap
30163436
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
28522
Gross Profit
-28522
Operating Expenses
614916
Operating Income
-1235720
Interest Expense
743435
Pretax Income
-1949279
Net Income
-919438
Eps
-0.0019161837712515593
Dividends Per Share
-
Shares Outstanding
502723932
Income Tax Expense
-110403
EBITDA
-600655
Operating Margin
-
Total Other Income Expense Net
-713559
Cash
396648
Short Term Investments
-
Receivables
155365
Inventories
-
Total Current Assets
1501492
Property Plant Equipment
74284
Total Assets
1580779
Payables
1244080
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1244080
Equity
336699
Bs_currency_symbol
GBP
Depreciation
14261
Change In Working Capital
49300
Cash From Operations
-1003026
Capital Expenditures
0
Cash From Investing
5889
Cash From Financing
1187485
Net Change In Cash
159746
Cf_currency_symbol
-
PE
-
PB
10260.675694314506
ROE
-273.07417010445533
ROA
-58.16360161667128
FCF
-1003026
Fcf Percent
-
Piotroski FScore
0
Health Score
16
Deep Value Investing Score
1.5
Defensive Investing Score
4.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
2
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
28522
Quarters > 0 > income Statement > gross Profit
-28522
Quarters > 0 > income Statement > operating Expenses
614916
Quarters > 0 > income Statement > operating Income
-1235720
Quarters > 0 > income Statement > interest Expense
743435
Quarters > 0 > income Statement > pretax Income
-1949279
Quarters > 0 > income Statement > net Income
-919438
Quarters > 0 > income Statement > eps
-0.0019161837712515593
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
479827673
Quarters > 0 > income Statement > income Tax Expense
-110403
Quarters > 0 > income Statement > EBITDA
-600655
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-713559
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
396648
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
155365
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1501492
Quarters > 0 > balance Sheet > property Plant Equipment
74284
Quarters > 0 > balance Sheet > total Assets
1580779
Quarters > 0 > balance Sheet > payables
1244080
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1244080
Quarters > 0 > balance Sheet > equity
336699
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-919438
Quarters > 0 > cash Flow > depreciation
14261
Quarters > 0 > cash Flow > change In Working Capital
49300
Quarters > 0 > cash Flow > cash From Operations
-1003026
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
5889
Quarters > 0 > cash Flow > cash From Financing
1187485
Quarters > 0 > cash Flow > net Change In Cash
159746
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0019161837712515593
Quarters > 0 > ratios > PB
10260.675694314506
Quarters > 0 > ratios > ROE
-273.07417010445533
Quarters > 0 > ratios > ROA
-58.16360161667128
Quarters > 0 > ratios > FCF
-1003026
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
614916
Quarters > 1 > income Statement > operating Income
-614916
Quarters > 1 > income Statement > interest Expense
359724
Quarters > 1 > income Statement > pretax Income
-974639
Quarters > 1 > income Statement > net Income
-919438
Quarters > 1 > income Statement > eps
-0.0019161837712515593
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
479827673
Quarters > 1 > income Statement > income Tax Expense
55202
Quarters > 1 > income Statement > EBITDA
-600655
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-359723
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
396648
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
155365
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1501492
Quarters > 1 > balance Sheet > property Plant Equipment
74284
Quarters > 1 > balance Sheet > total Assets
1580779
Quarters > 1 > balance Sheet > payables
1244080
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1244080
Quarters > 1 > balance Sheet > equity
336699
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-919438
Quarters > 1 > cash Flow > depreciation
14261
Quarters > 1 > cash Flow > change In Working Capital
49300
Quarters > 1 > cash Flow > cash From Operations
-502568
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
3999
Quarters > 1 > cash Flow > cash From Financing
593743
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0019161837712515593
Quarters > 1 > ratios > PB
10260.675694314506
Quarters > 1 > ratios > ROE
-273.07417010445533
Quarters > 1 > ratios > ROA
-58.16360161667128
Quarters > 1 > ratios > FCF
-502568
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
45038
Quarters > 2 > income Statement > gross Profit
-45038
Quarters > 2 > income Statement > operating Expenses
1471175
Quarters > 2 > income Statement > operating Income
-1516213
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2184603
Quarters > 2 > income Statement > net Income
-1048000
Quarters > 2 > income Statement > eps
-0.0025165871428331297
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
416437000
Quarters > 2 > income Statement > income Tax Expense
-88956
Quarters > 2 > income Statement > EBITDA
-933000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-668390
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
236902
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
429148
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
884868
Quarters > 2 > balance Sheet > property Plant Equipment
82321
Quarters > 2 > balance Sheet > total Assets
977011
Quarters > 2 > balance Sheet > payables
510549
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1519870
Quarters > 2 > balance Sheet > equity
-542859
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1047824
Quarters > 2 > cash Flow > depreciation
22519
Quarters > 2 > cash Flow > change In Working Capital
147877
Quarters > 2 > cash Flow > cash From Operations
-889970
Quarters > 2 > cash Flow > capital Expenditures
826
Quarters > 2 > cash Flow > cash From Investing
-190300
Quarters > 2 > cash Flow > cash From Financing
208629
Quarters > 2 > cash Flow > net Change In Cash
-847538
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0025165871428331297
Quarters > 2 > ratios > PB
-5523.2507888788805
Quarters > 2 > ratios > ROE
193.0519711379935
Quarters > 2 > ratios > ROA
-107.2659366168856
Quarters > 2 > ratios > FCF
-890796
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
955538
Quarters > 3 > income Statement > operating Income
-956000
Quarters > 3 > income Statement > interest Expense
82603
Quarters > 3 > income Statement > pretax Income
-1092000
Quarters > 3 > income Statement > net Income
-1048000
Quarters > 3 > income Statement > eps
-0.0025165871428331297
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
416437000
Quarters > 3 > income Statement > income Tax Expense
-44478
Quarters > 3 > income Statement > EBITDA
-933000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-137000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
236902
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
884868
Quarters > 3 > balance Sheet > property Plant Equipment
82321
Quarters > 3 > balance Sheet > total Assets
977011
Quarters > 3 > balance Sheet > payables
510549
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1519870
Quarters > 3 > balance Sheet > equity
-542859
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1047824
Quarters > 3 > cash Flow > depreciation
22519
Quarters > 3 > cash Flow > change In Working Capital
147877
Quarters > 3 > cash Flow > cash From Operations
-446190
Quarters > 3 > cash Flow > capital Expenditures
826
Quarters > 3 > cash Flow > cash From Investing
-92953
Quarters > 3 > cash Flow > cash From Financing
103323
Quarters > 3 > cash Flow > net Change In Cash
-1084440
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0025165871428331297
Quarters > 3 > ratios > PB
-5523.2507888788805
Quarters > 3 > ratios > ROE
193.0519711379935
Quarters > 3 > ratios > ROA
-107.2659366168856
Quarters > 3 > ratios > FCF
-447016
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
63880
Annuals > 0 > income Statement > gross Profit
-63880
Annuals > 0 > income Statement > operating Expenses
2675000
Annuals > 0 > income Statement > operating Income
-2280000
Annuals > 0 > income Statement > interest Expense
1984
Annuals > 0 > income Statement > pretax Income
-2779000
Annuals > 0 > income Statement > net Income
-2483000
Annuals > 0 > income Statement > eps
-0.005962486522571241
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
416437000
Annuals > 0 > income Statement > income Tax Expense
-295871
Annuals > 0 > income Statement > EBITDA
-2611000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-104000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
236902
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
429148
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
884868
Annuals > 0 > balance Sheet > property Plant Equipment
82321
Annuals > 0 > balance Sheet > total Assets
977011
Annuals > 0 > balance Sheet > payables
510549
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1519870
Annuals > 0 > balance Sheet > equity
-542859
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-2483499
Annuals > 0 > cash Flow > depreciation
63880
Annuals > 0 > cash Flow > change In Working Capital
68563
Annuals > 0 > cash Flow > cash From Operations
-1769105
Annuals > 0 > cash Flow > capital Expenditures
1652
Annuals > 0 > cash Flow > cash From Investing
1293635
Annuals > 0 > cash Flow > cash From Financing
500017
Annuals > 0 > cash Flow > net Change In Cash
28420
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.005962486522571241
Annuals > 0 > ratios > PB
-4710.105533849489
Annuals > 0 > ratios > ROE
457.39317207599026
Annuals > 0 > ratios > ROA
-254.142481507373
Annuals > 0 > ratios > FCF
-1770757
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
37607
Annuals > 1 > income Statement > gross Profit
-37607
Annuals > 1 > income Statement > operating Expenses
3145281
Annuals > 1 > income Statement > operating Income
-3063000
Annuals > 1 > income Statement > interest Expense
1986
Annuals > 1 > income Statement > pretax Income
-3419000
Annuals > 1 > income Statement > net Income
-2922000
Annuals > 1 > income Statement > eps
-0.008071711716688997
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
362005000
Annuals > 1 > income Statement > income Tax Expense
-497000
Annuals > 1 > income Statement > EBITDA
-3025000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-356000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
208481
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
451546
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
1343199
Annuals > 1 > balance Sheet > property Plant Equipment
102075
Annuals > 1 > balance Sheet > total Assets
2721411
Annuals > 1 > balance Sheet > payables
776186
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1665122
Annuals > 1 > balance Sheet > equity
1056289
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-2921795
Annuals > 1 > cash Flow > depreciation
37607
Annuals > 1 > cash Flow > change In Working Capital
469601
Annuals > 1 > cash Flow > cash From Operations
-1364407
Annuals > 1 > cash Flow > capital Expenditures
2
Annuals > 1 > cash Flow > cash From Investing
188762
Annuals > 1 > cash Flow > cash From Financing
722096
Annuals > 1 > cash Flow > net Change In Cash
-459332
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.008071711716688997
Annuals > 1 > ratios > PB
2104.2637952302825
Annuals > 1 > ratios > ROE
-276.6288392665265
Annuals > 1 > ratios > ROA
-107.37077200026015
Annuals > 1 > ratios > FCF
-1364409
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
117563
Annuals > 2 > income Statement > gross Profit
-118000
Annuals > 2 > income Statement > operating Expenses
2911389
Annuals > 2 > income Statement > operating Income
-3029000
Annuals > 2 > income Statement > interest Expense
2036
Annuals > 2 > income Statement > pretax Income
-4456000
Annuals > 2 > income Statement > net Income
-3807000
Annuals > 2 > income Statement > eps
-0.012567965059274445
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
302913000
Annuals > 2 > income Statement > income Tax Expense
-649000
Annuals > 2 > income Statement > EBITDA
-2911000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1427000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
667813
Annuals > 2 > balance Sheet > short Term Investments
-82563
Annuals > 2 > balance Sheet > receivables
649401
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
2338951
Annuals > 2 > balance Sheet > property Plant Equipment
389716
Annuals > 2 > balance Sheet > total Assets
3974701
Annuals > 2 > balance Sheet > payables
1071140
Annuals > 2 > balance Sheet > short Term Debt
111
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1451324
Annuals > 2 > balance Sheet > equity
2523377
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-3028952
Annuals > 2 > cash Flow > depreciation
117563
Annuals > 2 > cash Flow > change In Working Capital
-428776
Annuals > 2 > cash Flow > cash From Operations
-2347065
Annuals > 2 > cash Flow > capital Expenditures
106009
Annuals > 2 > cash Flow > cash From Investing
-77424
Annuals > 2 > cash Flow > cash From Financing
1547730
Annuals > 2 > cash Flow > net Change In Cash
-981561
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.012567965059274445
Annuals > 2 > ratios > PB
737.0622067174266
Annuals > 2 > ratios > ROE
-150.86925180026606
Annuals > 2 > ratios > ROA
-95.78078954869812
Annuals > 2 > ratios > FCF
-2453074
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
118350
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
118350
Annuals > 3 > income Statement > operating Expenses
6705305
Annuals > 3 > income Statement > operating Income
-6587000
Annuals > 3 > income Statement > interest Expense
124063
Annuals > 3 > income Statement > pretax Income
-8941000
Annuals > 3 > income Statement > net Income
-8174000
Annuals > 3 > income Statement > eps
-0.03254447293401921
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
251164000
Annuals > 3 > income Statement > income Tax Expense
-767000
Annuals > 3 > income Statement > EBITDA
-8703000
Annuals > 3 > income Statement > operating Margin
-5565.694972539079
Annuals > 3 > income Statement > total Other Income Expense Net
-2354000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
1649374
Annuals > 3 > balance Sheet > short Term Investments
-405489
Annuals > 3 > balance Sheet > receivables
373253
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
3345928
Annuals > 3 > balance Sheet > property Plant Equipment
352996
Annuals > 3 > balance Sheet > total Assets
5997801
Annuals > 3 > balance Sheet > payables
1155896
Annuals > 3 > balance Sheet > short Term Debt
700
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1584304
Annuals > 3 > balance Sheet > equity
4413497
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-6586955
Annuals > 3 > cash Flow > depreciation
114119
Annuals > 3 > cash Flow > change In Working Capital
631597
Annuals > 3 > cash Flow > cash From Operations
-4833172
Annuals > 3 > cash Flow > capital Expenditures
50934
Annuals > 3 > cash Flow > cash From Investing
-50283
Annuals > 3 > cash Flow > cash From Financing
702047
Annuals > 3 > cash Flow > net Change In Cash
-4212683
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.03254447293401921
Annuals > 3 > ratios > PB
349.41611153241973
Annuals > 3 > ratios > ROE
-185.20461212503375
Annuals > 3 > ratios > ROA
-136.28328115587695
Annuals > 3 > ratios > FCF
-4884106
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-41.268322771440644
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.0019161837712515593
Valuation > metrics > PB
10260.675694314506
Valuation > final Score
20
Valuation > verdict
341922.5% Overvalued
Profitability > metrics > ROE
-273.07417010445533
Profitability > metrics > ROA
-61.23495829481609
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.6949322688811073
Risk > metrics > Interest Coverage
-1.6621762494367363
Risk > final Score
-1
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.2069095235033116
Liquidity > metrics > Quick Ratio
1.2069095235033116
Liquidity > final Score
80
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-1
Prev Risks > 1
25
Prev Risks > 2
-16
Prev Liquidities > 0
80
Prev Liquidities > 1
93
Prev Liquidities > 2
93
Updated At
2026-01-20T23:02:05.813Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-18
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-22
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-09-09
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-09-30
Earnings History > 4 > report Date
2023-11-29
Earnings History > 4 > date
2023-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-06-30
Earnings History > 5 > report Date
2023-08-31
Earnings History > 5 > date
2023-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-05-11
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-30
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-09-30
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-03-31
Earnings History > 9 > report Date
2022-05-25
Earnings History > 9 > date
2022-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.02
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-09-30
Earnings History > 10 > report Date
2021-12-01
Earnings History > 10 > date
2021-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-06-30
Earnings History > 11 > report Date
2021-09-29
Earnings History > 11 > date
2021-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-03-31
Earnings History > 12 > report Date
2021-04-29
Earnings History > 12 > date
2021-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.02
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2020-09-30
Earnings History > 13 > report Date
2020-12-02
Earnings History > 13 > date
2020-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2020-06-30
Earnings History > 14 > report Date
2020-09-30
Earnings History > 14 > date
2020-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.02
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2020-03-31
Earnings History > 15 > report Date
2020-04-30
Earnings History > 15 > date
2020-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-09-30
Earnings History > 16 > report Date
2019-11-27
Earnings History > 16 > date
2019-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2019-06-30
Earnings History > 17 > report Date
2019-09-30
Earnings History > 17 > date
2019-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.03
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2019-03-31
Earnings History > 18 > report Date
2019-05-24
Earnings History > 18 > date
2019-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
-0.02
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2018-09-30
Earnings History > 19 > report Date
2018-11-28
Earnings History > 19 > date
2018-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2018-06-30
Earnings History > 20 > report Date
2018-09-26
Earnings History > 20 > date
2018-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
-0.03
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.03
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2018-03-31
Earnings History > 21 > report Date
2018-05-29
Earnings History > 21 > date
2018-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
-0.02
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2017-06-30
Earnings History > 22 > report Date
2017-09-27
Earnings History > 22 > date
2017-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
-0.02
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.02
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-03-31
Earnings History > 23 > report Date
2017-06-01
Earnings History > 23 > date
2017-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
GBP
Earnings History > 23 > eps Actual
-0.01
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.01
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2016-06-30
Earnings History > 24 > report Date
2016-09-30
Earnings History > 24 > date
2016-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
GBP
Earnings History > 24 > eps Actual
-0.03
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.03
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2016-03-31
Earnings History > 25 > report Date
2016-05-04
Earnings History > 25 > date
2016-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
GBP
Earnings History > 25 > eps Actual
-0.03
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.03
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-06-30
Earnings History > 26 > report Date
2014-09-22
Earnings History > 26 > date
2014-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
GBP
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-03-31
Earnings History > 27 > report Date
2014-06-02
Earnings History > 27 > date
2014-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
GBP
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company's lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140, which is in Phase II clinical trial for the treatment of chronic inflammatory demyelinating polyneuropathy, a rare acquired autoimmune disorder of peripheral nerve; and P140 that covers other indications acute and chronic asthma, gout, irritable bowel disease, and periodontitis. Its pre-clinical products include BioAMB, a peptide-based drug of Amphotericin-B formulations for the treatment of serious and life-threatening fungal infections, such as aspergillosis; and BioCin, a vancomycin based treatment for anti-infection. It has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of 1P40 platform; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AImmuPharma plc (LSE:IMM) Activity Rises Across the FTSE AIM All-Share Landscape - Kalkine Media
12/8/2025
ImmuPharma plc (LSE:IMM) Activity Rises Across the FTSE AIM All-Share Landscape Kalkine Media
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of ImmuPharma PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.